| ¹ßÇ¥Çü½Ä :
|
Á¢¼ö¹øÈ£ - 990087 OTOP 7-3 |
| DEVELOPMENT OF OPTOGENETIC MICRONEEDLE FOR MINIMALLY INVASIVE NEURO-
STIMULATION OF INNER EAR |
| 1DEPARTMENT OF OTORHINOLARYNGOLOGY–HEAD AND NECK SURGERY, SOONCHUNHYANG UNIVERSITY COLLEGE OF MEDICINE, CHEONAN, REPUBLIC OF KOREA 2DANKOOK UNIVERSITY HOSPITAL 3 DEPARTMENT OF OTORHINOLARYNGOLOGY–HEAD AND NECK SURGERY, COLLEGE OF MEDICINE, THE CATHOLIC UNIVERSITY OF KOREA, SEOUL, REPUBLIC OF KOREA. |
| SUBIN KIM,
SUBIN KIM1*, SO-YOUNG CHANG2*, KEUM-JIN YANG3, SEONG SU WON3, JIAE JEON3,JAE YUN JUNG2, DONG-KEE KIM3, MIN YOUNG LEE2
|
¸ñÀû: This study aims to develop an optogenetic microneedle system for
minimally invasive neuro-stimulation of the inner ear. The microneedle
is designed to deliver AAV viral vectors efficiently to the cochlea
via the round window membrane, enabling targeted expression of
optogenetic proteins in auditory neurons. By comparing microneedle-
mediated delivery with conventional microcatheter injection, we seek
to determine the efficacy and safety of this novel approach.
¹æ¹ý:A biodegradable hyaluronic acid-based microneedle was fabricated to
release AAV viral vectors directly into the cochlea¡¯s scala tympani.
In vitro experiments were conducted using assembloids, a combination
of cochlear progenitor organoids and spiral ganglion neurons, which
were incubated with microneedles containing AAV-mCherry-Halorhodopsin.
Epifluorescence analysis was performed to confirm viral transfection,
and multielectrode array (MEA) recordings were used to assess neuronal
responses to light stimulation.
For in vivo validation, rats were divided into experimental groups
receiving either AAV-GFP via microneedle or conventional viral
injection. Western blot analysis was conducted to quantify AAV-GFP
expression in cochlear tissue. Additionally, optogenetically
engineered rats underwent auditory brainstem response (ABR) testing
using a continuous 532 nm laser (0.38 mW) to evaluate functional
stimulation.
°á°ú:Western blot analysis revealed that microneedle-mediated AAV-GFP
delivery resulted in significantly higher GFP expression compared to
conventional injection, indicating improved efficiency of viral
transfection. Epifluorescence analysis showed strong transfection of
spiral ganglion neurons in the microneedle group, whereas conventional
delivery primarily transfected inner hair cells.
In assembloid models, AAV-mCherry-Halorhodopsin was successfully
expressed in both inner hair cells and neurons. When subjected to
light stimulation, these assembloids exhibited robust phase-locked
electrical activity, confirming functional optogenetic responses.
In vivo experiments demonstrated that rats receiving microneedle-
mediated AAV-mCherry-Halorhodopsin delivery exhibited laser-induced
ABR responses without acoustic stimuli. These responses were
characterized by irregular but increased amplitude waveforms upon
laser irradiation, suggesting successful neural activation through
optogenetic stimulation. °á·Ð:This study demonstrates that optogenetic microneedles can effectively
deliver viral vectors to cochlear target cells with high efficiency
and specificity. The ability of microneedle-delivered optogenetic
proteins to induce neural responses upon light stimulation suggests a
viable alternative to conventional electrical stimulation methods.
These findings support the further development of bioengineered
microneedle systems for non-invasive auditory neuro-stimulation,
potentially reducing the need for surgically implanted mechanical
devices. |
|